Security Snapshot

STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM) Institutional Ownership

CUSIP: 86323X106

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
4,279,000
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • STRM - STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value is tracked under CUSIP 86323X106.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q2 2025 and Q3 2025.
  • SEC-reported value moved from $1,038,000 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

86323X106

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
STRM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Tamarack Advisers, LP 3.6% $35,430 154,044 Ferayorni Justin John 13 Nov 2024

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
47
Latest
n/a
Rows shown
1-25 of 47
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$1,038,000 0
2025 Q2 200,000 $1,038,000 +$1,038,000 $5.19 1
2025 Q1 0 $0 -$230 0
2024 Q4 0 $0 -$2,015,639 0
2024 Q3 8,760,612 $2,015,639 -$1,722,043 $0.23 23
2024 Q2 12,386,588 $5,719,610 +$4,130 $0.46 29
2024 Q1 12,286,476 $5,898,517 -$196,296 $0.48 28
2023 Q4 17,743,035 $7,561,600 -$349,112 $0.42 39
2023 Q3 17,883,693 $17,266,568 -$1,226,521 $0.97 43
2023 Q2 19,143,429 $24,292,810 +$148,873 $1.27 39
2023 Q1 18,942,356 $34,066,810 +$1,806,661 $1.80 37
2022 Q4 17,944,848 $28,343,327 +$2,613,366 $1.58 37
2022 Q3 16,375,130 $19,466,900 +$5,714,521 $1.19 29
2022 Q2 11,568,957 $14,685,700 -$202,813 $1.27 24
2022 Q1 11,703,066 $18,724,000 -$7,236,951 $1.60 27
2021 Q4 16,598,901 $24,686,000 -$1,330,145 $1.47 26
2021 Q3 17,411,227 $30,465,500 -$1,748,772 $1.75 29
2021 Q2 18,406,782 $32,568,700 -$1,261,446 $1.77 32
2021 Q1 18,962,602 $38,835,500 +$11,453,580 $2.05 33
2020 Q4 14,051,323 $22,135,600 +$423,040 $1.56 29
2020 Q3 13,865,990 $21,632,600 +$203,880 $1.56 27
2020 Q2 13,312,215 $17,706,566 +$580,695 $1.33 25
2020 Q1 13,333,474 $11,331,670 -$1,105,824 $0.85 27
2019 Q4 14,133,488 $19,646,178 +$7,212,586 $1.39 26
2019 Q3 8,973,869 $9,745,220 +$159,990 $1.08 27
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .